158 related articles for article (PubMed ID: 11249490)
1. Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.
Staresinic AG; Sorkness CA
Expert Opin Pharmacother; 2000 Sep; 1(6):1227-44. PubMed ID: 11249490
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC; Hallett C; Harris TA
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
Karakoç F; Karadag B; Kut A; Ersu R; Bakaç S; Cebeci D; Dagli E
J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
[TBL] [Abstract][Full Text] [Related]
4. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
5. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED; Silins V; Bogolubov M
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
[TBL] [Abstract][Full Text] [Related]
7. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone versus beclomethasone or budesonide for chronic asthma.
Adams N; Bestall JM; Jones PW
Cochrane Database Syst Rev; 2002; (1):CD002310. PubMed ID: 11869636
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled corticosteroids: first-line therapy in asthma].
Hajiro T; Ishihara K
Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
[TBL] [Abstract][Full Text] [Related]
11. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
12. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
Holliday SM; Faulds D; Sorkin EM
Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
[TBL] [Abstract][Full Text] [Related]
13. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
Adams N; Bestall JM; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2005 Apr; (2):CD002310. PubMed ID: 15846637
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
15. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ; Martin RJ; King TS; Boushey HA; Cherniack RM; Chinchilli VM; Craig TJ; Dolovich M; Drazen JM; Fagan JK; Fahy JV; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lazarus SC; Lemanske RF; Mauger E; Peters SP; Sorkness CA;
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[TBL] [Abstract][Full Text] [Related]
16. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.
Rutherford C; Mills R; Gibson PG; Price MJ
Respirology; 2003 Sep; 8(3):371-5. PubMed ID: 12911833
[TBL] [Abstract][Full Text] [Related]
17. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ; Halpin DM; Stein K
BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
[TBL] [Abstract][Full Text] [Related]
18. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD; Moore A; Mersmann S; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[TBL] [Abstract][Full Text] [Related]
19. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis.
Storms WW
J Asthma; 1998; 35(4):313-36. PubMed ID: 9669826
[TBL] [Abstract][Full Text] [Related]
20. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
